Innovative orthopaedic injection will soon be available at Mount Alvernia Hospital
Guildford’s Mount Alvernia Hospital has launched an innovative new orthopaedic injection service, available to patients across Surrey, the new treatment will help patients who are unable to have knee replacement surgery. Arthrosamid has been described as ‘game-changing’ for patients who suffer with osteoarthritis and is available now at the 47-bed private hospital.
Arthrosamid is a polyacrylamide hydrogel, which can be injected into the knees to help patients suffering with osteoarthritis, a condition that causes joints to become painful and stiff. It is estimated that 8.5 million people in the UK (around 1 in 5 people aged over 45 in England) suffer from Osteoarthritis, the launch of this new treatment, will ensure that those suffering with the condition have access to a non-surgical treatment.
Not every person suffering with osteoarthritis will be eligible for surgery, Arthrosamid represents an innovative solution to managing the condition, relieving symptoms effectively and without the need for an operation.
Mr Oliver Templeton-Ward, Consultant Orthopaedic Surgeon and knee specialist at Mount Alvernia Hospital, said:
“Arthrosamid represents an important advancement in joint-care innovation. Arthrosamid focuses on long-lasting treatment and improved mobility. It has the potential to offer meaningful support to people seeking relief from persistent knee discomfort whilst avoiding major joint replacement surgery. We are seeing growing interest from clinicians and patients alike in Arthrosamid and it is well-positioned to become a trusted option in the evolving landscape of joint-health solutions. I am delighted to be able to offer this cutting-edge treatment to my patients at Mount Alvernia”
Patients will see Mr Templeton-Ward for their initial consultation and will then be referred to Mr Chintu Gademsetty who will perform the procedure.
Following over 20 years of clinical trials, Arthrosamid was approved to be used in the UK by the Medicines and Healthcare Products Regulatory Agency (MHRA) in 2021. Available at other Circle Health Group hospitals, this is the first time that patients at Mount Alvernia Hospital will be able to access the treatment.
Package prices start from £2,889 for a single knee and from £5,536 for both knees. Patient’s looking to book with Mount Alvernia Hospital will also have the option to add four physiotherapy sessions for an additional £220.
Patients interested in finding out more encouraged to contact Mount Alvernia Hospital directly on 01483 442 695.
Nichola Evans,Executive Director of Mount Alvernia Hospital, said:
“We are committed to being at the forefront of innovation, providing our patients with access to the latest technology and treatment options. Arthrosamid represents a significant opportunity for us to meet the needs of thousands more patients each year. We look forward to launching the service on 1 December and supporting those suffering from osteoarthritis to get back to doing the things they love faster than ever.”